COVID-19 Clinical Trial
Official title:
Assessment of the Consequences of the Abrupt Interruption of Physical and Rehabilitation Medicine Consultations During the Quarantine Period in France Between 2020 March 17th and May 11th
Objectives This survey aims at reporting the immediate impact of the COVID-19 epidemic on
outpatients followed in Physical and Rehabilitation Medicine (PRM). It focuses on the
disruption of PRM healthcare services during the quarantine period in France between 2020
March 17th and May 11th and on its medical consequences.
Method This observational study was conducted in the PRM department of a French University
Hospital. Outpatients whose PRM medical consultation had been cancelled were contacted by
phone between April 9th, 2020 and May 7th, 2020. A structured questionnaire was fulfilled for
each patient.
Demographical and medical data were recorded, including the disabling diseases motivating the
PRM outpatients' follow-up. The necessity to perform an immediate phone consultation or to
schedule an urgent consultation within the next 3 weeks constituted the main judgment
criterion. Other recorded criteria were: the reason for this urgent need of a medical
consultation, the access to other medical services during the quarantine period, the
interruption of home-based rehabilitation services and its perceived consequences for the
patients.
The PRM Department of Montpellier University Hospital usually provides between 8500 and 9500
medical consultations/year. A total of 830 medical consultations have been cancelled during
the lockdown for COVID-19 between March 17th, 2020, and May 11th, 2020. This survey was
approved by the local Institutional Review Board (IRB accreditation number: 19871).
Procedure Phone calls were performed by residents. These young doctors worked in the PRM
Department for 4 months before the beginning of the outbreak and were used to the PRM medical
practices of the senior practitioners. They received a special dedicated education before
they start calling the patients. They fulfilled a structured questionnaire for each patient.
Each resident was supervised by a senior MD. A personalized daily appointment was organized
with the group of residents to check for difficulties in recording the data and to answer any
question from them. Questionnaires were collected each day and data were daily implemented in
a dedicated database.
Data recorded Descriptive data concerning age, description of the underlying disease, and
delay from the cancelled consultation were recorded at the beginning of the call.
The main Judgment criterion is the necessity to schedule a medical consultation within the
next 3 weeks: immediate telephone consultation for urgent but easy situations (like refilling
a prescription or advising the patient), or short-term consultation within the next three
weeks. Other patients have been proposed for a delayed consultation within the next 3 months.
Secondary objectives are: 1/ the reason for this urgent need of a medical consultation within
the next 3 weeks, 2/ the category of patients for whom this need was the most prevalent,
3/the relationship between the date of the cancelled consultation and the feeling of
emergency for reprogramming it, 4/ the disruption of home-based or community-based
rehabilitation and its consequences for patients, and 5/ the access to other medical services
for those patients during the quarantine period.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT06065033 -
Exercise Interventions in Post-acute Sequelae of Covid-19
|
N/A | |
| Completed |
NCT06267534 -
Mindfulness-based Mobile Applications Program
|
N/A | |
| Completed |
NCT05047601 -
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04481633 -
Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection
|
N/A | |
| Recruiting |
NCT05323760 -
Functional Capacity in Patients Post Mild COVID-19
|
N/A | |
| Completed |
NCT04537949 -
A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults
|
Phase 1/Phase 2 | |
| Completed |
NCT04612972 -
Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru
|
Phase 3 | |
| Recruiting |
NCT05494424 -
Cognitive Rehabilitation in Post-COVID-19 Condition
|
N/A | |
| Active, not recruiting |
NCT06039449 -
A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2
|
Phase 3 | |
| Enrolling by invitation |
NCT05589376 -
You and Me Healthy
|
||
| Completed |
NCT05158816 -
Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
|
||
| Recruiting |
NCT04341506 -
Non-contact ECG Sensor System for COVID19
|
||
| Completed |
NCT04384445 -
Zofin (Organicell Flow) for Patients With COVID-19
|
Phase 1/Phase 2 | |
| Completed |
NCT04512079 -
FREEDOM COVID-19 Anticoagulation Strategy
|
Phase 4 | |
| Completed |
NCT05975060 -
A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants.
|
Phase 2/Phase 3 | |
| Active, not recruiting |
NCT05542862 -
Booster Study of SpikoGen COVID-19 Vaccine
|
Phase 3 | |
| Terminated |
NCT05487040 -
A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease
|
Phase 1 | |
| Withdrawn |
NCT05621967 -
Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation
|
N/A | |
| Terminated |
NCT04498273 -
COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80
|
Phase 3 | |
| Active, not recruiting |
NCT06033560 -
The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure
|